Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Virios Therapeutics Inc
(NQ:
VIRI
)
0.2094
+0.0304 (+16.98%)
Streaming Delayed Price
Updated: 3:59 PM EDT, May 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Virios Therapeutics Inc
< Previous
1
2
3
4
5
6
7
Next >
An Innovative Approach To Antiviral Therapies And Treating Fibromyalgia (FM) Disease?
February 02, 2022
Photo by Fusion Medical Animation on Unsplash Greg Duncan, Chairman and CEO of Virios Therapeutics Inc. (NASDAQ: VIRI), was a guest speaker at Benzinga’s All Access on Jan. 28, 2022.
Via
Benzinga
Benzinga Announces This Week's All Access Guests
January 27, 2022
Benzinga is thrilled to announce the guest lineup for our next All Access show, presented by RedChip, set to air Friday, January 28 at 9:15 am ET. The Lineup 9:15 am:...
Via
Benzinga
RedChip Partners with Benzinga to Host Exclusive Small-Cap CEO Interview Series on January 28
January 26, 2022
ORLANDO, FL / ACCESSWIRE / January 26, 2022 / RedChip Companies, Inc., an international investor relations, media, and research firm focused on microcap and small-cap companies, is pleased to announce...
From
RedChip
Via
AccessWire
Virios Therapeutics to Present at the Virtual H.C. Wainwright BioConnect Conference
January 04, 2022
From
Virios Therapeutics, Inc. (VIRI)
Via
Business Wire
Earnings Scheduled For November 11, 2021
November 11, 2021
Companies Reporting Before The Bell • NICE (NASDAQ:NICE) is likely to report quarterly earnings at $1.58 per share on revenue of $465.75 million. • Reshape...
Via
Benzinga
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
August 08, 2021
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,...
Via
Benzinga
Exposures
Product Safety
Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2021
December 15, 2021
Upgrades B of A Securities upgraded the previous rating for ONE Gas Inc (NYSE:
Via
Benzinga
Virios Therapeutics Achieves Over 50% Enrollment Milestone in its Phase 2b Clinical Trial for Fibromyalgia
December 01, 2021
From
Virios Therapeutics, Inc. (VIRI)
Via
Business Wire
Virios Therapeutics Announces Third Quarter 2021 Financial Results and Provides Corporate Update
November 11, 2021
From
Virios Therapeutics, Inc. (VIRI)
Via
Business Wire
Virios Therapeutics to Report Third Quarter 2021 Financial Results and Provide Corporate Update on Thursday, November 11, 2021
November 04, 2021
From
Virios Therapeutics, Inc. (VIRI)
Via
Business Wire
64 Biggest Movers From Yesterday
November 02, 2021
Gainers ABVC BioPharma, Inc. (NASDAQ: ABVC) shares climbed 137.4% to close at $6.03 on Monday on abnormally-high volume. The stock is seeing increased interest by traders on...
Via
Benzinga
Virios Therapeutics Granted New Patent for Antiviral Inhibitor Combination
September 08, 2021
From
Virios Therapeutics, Inc.
Via
Business Wire
Virios Therapeutics to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
September 02, 2021
From
Virios Therapeutics, Inc. (VIRI)
Via
Business Wire
Stocks That Hit 52-Week Lows On Friday
August 20, 2021
On Friday morning, 155 companies achieved new lows for the year. Interesting Points: Marqeta (NASDAQ:MQ) was the largest firm on a market cap basis to set a new 52-...
Via
Benzinga
Virios Therapeutics Announces New Social Media Profiles
August 19, 2021
From
Virios Therapeutics, Inc.
Via
Business Wire
Virios Therapeutics CEO Highlights Novel Therapeutic Approach for Treating Fibromyalgia and Irritable Bowel Syndrome in Stock News Now Video Interview
August 16, 2021
From
Virios Therapeutics, Inc.
Via
Business Wire
Virios Therapeutics Announces Second Quarter 2021 Financial Results and Provides Corporate Update
August 12, 2021
From
Virios Therapeutics, Inc.
Via
Business Wire
Keynotes, Educational Panels and 60 Companies to Present at the SNN Network Summer Virtual Event on August 17-19, 2021
August 16, 2021
LOS ANGELES, CA / ACCESSWIRE / August 16, 2021 / The SNN Network Summer Virtual Event will take place on August 17-19, 2021, where 60 SmallCap, MicroCap and NanoCap public and private companies will be...
From
Stock News Now
Via
AccessWire
Topics
Cannabis
Exposures
Cannabis
The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma
August 12, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11) Adagio Therapeutics, Inc. (...
Via
Benzinga
Exposures
Product Safety
Earnings Scheduled For August 12, 2021
August 12, 2021
Companies Reporting Before The Bell • Anavex Life Sciences (NASDAQ:AVXL) is estimated to report earnings for its third quarter. • ITeos Therapeutics (NASDAQ:ITOS...
Via
Benzinga
Virios Therapeutics to Present at the SNN Network Summer Virtual Conference
August 11, 2021
From
Virios Therapeutics, Inc. (VIRI)
Via
Business Wire
Virios Therapeutics Featured in Bloomberg TV Interview
August 09, 2021
From
Virios Therapeutics, Inc. (VIRI)
Via
Business Wire
Virios Therapeutics to Report Second Quarter 2021 Financial Results and Provide Corporate Update on Thursday, August 12, 2021
August 05, 2021
From
Virios Therapeutics, Inc. (VIRI)
Via
Business Wire
Virios Therapeutics Highlights Clinical Sites Fully Operational in Phase 2b Fibromyalgia Study Featuring FDA “Fast Track” Review Designated Antiviral Therapy, Oral IMC-1
July 26, 2021
From
Virios Therapeutics, Inc. (VIRI)
Via
Business Wire
Fibromyalgia Treatment: 3 Pillars that Set Virios Therapeutics Apart from the Rest
July 08, 2021
The success of any company most often begins with a solid foundation and strong pillars. These two are essential ingredients to the growth of a company. Weak foundations or...
Via
Benzinga
Virios Therapeutics Stock Moves Higher On Promising IMC-1 Safety Data In Mid-Stage Fibromyalgia Trial
June 09, 2021
Virios Therapeutics Inc (NASDAQ: VIRI) has announced that data from its Phase 2a PRID-201 trial demonstrated that IMC-1 was better tolerated than placebo in...
Via
Benzinga
Virios Therapeutics Highlights Safety Data from Phase 2a Fibromyalgia Trial at the International Association for the Study of Pain (IASP) World Congress
June 09, 2021
From
Virios Therapeutics, Inc.
Via
Business Wire
62 Biggest Movers From Yesterday
June 10, 2021
Gainers Aethlon Medical, Inc. (NASDAQ: AEMD) shares surged 388.2% to close at $10.79 on Wednesday in reaction to Zacks Article 'AEMD: First Ever In Vivo Removal Of COVID...
Via
Benzinga
Virios Therapeutics Announces Dosing of First Patient in Phase 2b Trial Evaluating IMC-1 in Patients with Fibromyalgia
June 04, 2021
From
Virios Therapeutics, Inc. (VIRI)
Via
Business Wire
48 Stocks Moving In Wednesday's Mid-Day Session
June 09, 2021
Gainers Aethlon Medical, Inc. (NASDAQ: AEMD) shares jumped 371% to $10.41 in reaction to Zacks Article 'AEMD: First Ever In Vivo Removal Of COVID Virus From Bloodstream Of An...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.